H.R. 2161 · 108th Congress
Prescription Value Act
- Stage
- In committee
- Sponsor
- Doug Bereuter
- Introduced
- 2003-05-20
- Latest action
- 2003-06-02 · Referred to the Subcommittee on Health.
Summary
Prescription Value Act - Directs the Director of the Agency for Healthcare Research and Quality to: (1) collect scientific evidence regarding the relative clinical appropriateness and cost-effectiveness of prescription drugs frequently used by Medicare and Medicaid beneficiaries; (2) assess the validity and reliability of such evidence; and (3) identify areas of additional research needed to make an objective determination on the clinical appropriateness and cost-effectiveness of such drugs.